Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Total Current Liabilities (2016 - 2020)

Historic Total Current Liabilities for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to $2.4 million.

  • Forte Biosciences' Total Current Liabilities fell 9422.46% to $2.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was $2.4 million, marking a year-over-year decrease of 9422.46%. This contributed to the annual value of $1.9 million for FY2019, which is 8843.6% down from last year.
  • Per Forte Biosciences' latest filing, its Total Current Liabilities stood at $2.4 million for Q3 2020, which was down 9422.46% from $3.4 million recorded in Q2 2020.
  • In the past 5 years, Forte Biosciences' Total Current Liabilities ranged from a high of $41.7 million in Q3 2019 and a low of $1.9 million during Q4 2019
  • For the 5-year period, Forte Biosciences' Total Current Liabilities averaged around $14.8 million, with its median value being $15.6 million (2017).
  • As far as peak fluctuations go, Forte Biosciences' Total Current Liabilities skyrocketed by 18604.91% in 2019, and later crashed by 9422.46% in 2020.
  • Over the past 5 years, Forte Biosciences' Total Current Liabilities (Quarter) stood at $14.4 million in 2016, then grew by 20.5% to $17.3 million in 2017, then decreased by 4.59% to $16.5 million in 2018, then plummeted by 88.44% to $1.9 million in 2019, then increased by 26.1% to $2.4 million in 2020.
  • Its last three reported values are $2.4 million in Q3 2020, $3.4 million for Q2 2020, and $12.6 million during Q1 2020.